Polypharmacy and High-Risk Patients
PharmaSim · Created · Updated
Educational material; no clinical peer review is claimed. Methodology and limitations
Polypharmacy — taking many medications — is common in older adults and in chronic disease. The risk is cumulative: the problem is often the combination, not any single drug. This article is educational and does not replace formal training.
Why this matters in pharmacy
Polypharmacy is a leading cause of preventable harm in older adults. Falls, bleeds, hypoglycemia, and confusion often trace back to an accumulated medication burden rather than a single faulty drug. The pharmacist is well placed to spot it.
Cumulative risk
Each added drug increases interaction risk, side effects, and the chance of a prescribing cascade (treating a side effect of one drug with another). The more drugs, the higher the risk — not because any one is wrong, but because of the combination.
Inappropriate drugs in older adults
Some drugs are inappropriate in older adults because they increase fall, confusion, or bleeding risk. First-generation antihistamines, long-term benzodiazepines, and certain anticholinergics are common examples. The Beers Criteria and similar tools list these.
The prescribing cascade
A side effect of one drug is misread as a new condition and treated with another drug, adding to the burden. Recognising a cascade — e.g., a drug causing edema that is then treated with a diuretic — is a valuable pharmacist observation.
The pharmacist's review role
The pharmacist does not deprescribe independently. They flag accumulated risk, suggest a formal medication review with the prescriber, counsel on safety in the interim, and document. Deprescribing is a prescriber decision.
Practical safety advice while a review is arranged
Counsel on standing up slowly to reduce postural hypotension, on reading labels to avoid hidden duplicate drugs, and on keeping an up-to-date list. These reduce harm while the structured review is pending.
Medication count is a signal, not a diagnosis
Several medicines may all have valid indications. Assess benefit, harm and practical burden for the individual rather than aiming for an arbitrary small number. Ask about falls, cognition, sleep, continence, dizziness, glucose symptoms and what matters most to the patient. Establish which drugs are actually used and whether a carer helps. A new fall or confusion deserves clinical assessment, not an assumption that ageing explains it.
Prioritise a useful review
Start with immediate risks: anticoagulant plus NSAID, duplicate therapy, hypoglycaemia-provoking regimens, sedation and anticholinergic burden. Then examine indication, monitoring, duration and possible prescribing cascades. An oedema treatment may be addressing an adverse effect rather than a new disease. Tools for potentially inappropriate prescribing support judgement but do not prohibit every listed drug in every older patient. Renal function and goals of care change the balance.
Counseling and a coordinated plan
Choose a responsible clinician to coordinate changes, particularly when several prescribers are involved. Deprescribing can require tapering and monitoring; abrupt withdrawal of a long-standing sedative or other important treatment can cause harm. Simplification should consider swallowing, dexterity, eyesight, affordability and daily routine. Provide one reconciled list and a clear review date, with interim safety advice and urgent signs. Do not reassure recurrent falls solely by advising the person to stand slowly.
Practical example
An elderly patient with dizziness on many drugs
A 78-year-old on seven medications reports dizziness on standing. The pharmacist recognises postural hypotension as a likely consequence of accumulated medication burden, flags it to the prescriber for a formal review, and counsels the patient on standing slowly in the interim. The pattern, not any single drug, is the concern.
Key takeaways
- Polypharmacy risk is cumulative — the problem is often the combination, not one drug.
- Some drugs are inappropriate in older adults (first-generation antihistamines, long-term benzodiazepines).
- Recognise prescribing cascades — a side effect treated as a new condition.
- Deprescribing is a prescriber decision; the pharmacist flags, counsels, and documents.
Sources and references
Sources reflect their own jurisdictions. For real practice, check the current product label and local guidance.
Practice this topic in PharmaSim
Start SimulationRelated clinical cases
Related articles
PharmaSim is an educational simulation designed for learning and practice. It does not replace formal pharmacy education, clinical training, official prescribing information, professional supervision, or professional judgment.